1

Updated: Sept. 08, 2020

[Project] – Clinical trial (served as a leading biostatistician)

1. Early versus delayed discontinuation of dual antiplatelet treatment in acute ischemic stroke with presumed atherothrombotic origin (DURATION), 2019 - Current [RRCT]

2. Moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin for target LDL-C goal achievement in patients with recent ischemic stroke: a randomized clinical trial (ROSETTA-Stroke),

Hanmi Pharmaceutical Co., Ltd., 2019 - Current [Phase IV]

3. Impact of immediate stent implantation versus deferred stent implantation on clinical outcomes in patients with anterior wall ST-segment elevation myocardial infarction (INNOVATION-CORE),

Department of Cardiology, KUMC, 2018 - Current [Phase IV, IIT]

4. Phase II study of trastuzumab plus gedatolisib in patients with HER-2 positive metastatic breast cancer who progressed after 2 or more HER-2 directed chemotherapy (KM-10), K-MASTER, 2018 - Current

[Phase Ib, Phase II]

5. A phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06), K-MASTER, 2018 -

Current [Phase II]

6. The effect of EGFR TKI treatment based on liquid biopsy panel screening in patients with non-small cell lung cancer (KM-05), K-MASTER, 2018 - Current [Phase II]

7. Phase II trial of AZD2014 in RICTOR amplified solid cancer patients refractory to standard chemotherapy (KM02-03), K-MASTER, 2018 - Current [Phase II]

8. Phase II trial of vistusertib (AZD2014) single agent in TSC1 or 2 null or TSC 1/2 mutation solid cancer patients refractory to standard chemotherapy (TSC1/2_SC) (KM02-02), K-MASTER, 2018 - Current

[Phase II]

9. The pilot study to evaluate the safety and efficacy of sirolimus, in subject with refractory solid tumors (KM02-01), K-MASTER, 2018 - Current [Phase II, Pilot]

10. Effectiveness and tolerability of novel, initial triple combination therapy with Kombiglyze (Saxagliptin plus metformin) and Dapagliflozin vs. conventional stepwise add-on therapy in drug-naïve patients with

type 2 diabetes (TRIPLE-AXEL), AstraZeneca Korea, 2016 – Current [Phase IV]

11. Oxiracetam with exercise in stroke survivors with subjective cognitive decline (OVeRCOME), Korean Drug Co., Ltd., 2015 - Current [Phase IV]

12. Optimization of blood pressure management after acute ischemic stroke and its prognostic significance: Prospective, randomized, open, blinded outcome evaluation, and feasibility Trial (BOSS – Trial I),

Daiichi Sankyo Korea Co., Ltd., 2015 - 2018 [Phase IIb, Feasibility]

13. Prevention of cardiovascular events in ischemic stroke patients with high risk of cerebral hemorrhage (PICASSO), Korea Otsuka Pharma. Co., Ltd., 2009 - 2017 [Phase IV]

14. Strategy for adequate blood pressure lowering in the patients with intracranial atherosclerosis (STABLE-ICAS), Pfizer Korea Inc., 2010 - 2017 [Phase IV]

15. The incidence of neutropenia in patients taking Yuclid for prevention of vascular events, Yuyu Pharma. Inc., 2009 - 2016 [PMS]

16. Post-marketing surveillance of evaluating safety and efficacy of TRISENOX, BL&H Inc., 2015 [PMS]

17. A study of investigating biologic markers of anti-tumor effects of zoledronic acid and taxane-based chemotherapy for metastatic breast cancer in bone: A prospective, multi-center, non-randomized study

(BEAT-ZO), The Korean Breast Cancer Study Group (KBCSG), 2012 - 2015 [Phase II]

18. Single-center, randomized, double-blinded, comparative study of the effectiveness of L-carnitine in patients’ fatigue degree changing with hypothyroidism who take thyroid hormone, Ildong Pharma. Co.

Ltd., 2012 - 2015 [Phase IV]

2

19. Effect of Rubus occidentalis extract on plasma glucose levels in subject with prediabetes: A proof-of-concept, randomized, double-blind, parallel-group, placebo-controlled study, Berry and Bio Food

Research Institute, 2013 - 2014 [Phase IV]

20. Prospective, randomized, open–label, blinded endpoints, multi-center study to evaluate the efficacy of modest blood pressure reduction with Diovan® (valsartan) in acute ischemic stroke (VENTURE),

Norvatis Korea Inc., 2010 - 2014 [Phase IV]

21. A randomized, double-blind, placebo-controlled phase IV trial for an evaluation of the efficacy of Gliatiline® on post-stroke patients with vascular cognitive impairment no dementia (GLITTER),

Daewoong Co., Ltd., 2010 - 2014 [Phase IV]

22. Assessment of quality of life and safety in postmenopausal breast cancer patients receiving LETROZOLE as an early adjuvant treatment, The Korean Breast Cancer Study Group (KBCSG), 2007 -

2014 [Phase IV]

23. The efficacy and safety of radiofrequency catheter ablation using CARTO 3D mapping system compared to conventional method in patients with atrial fibrillation and substrate-dependent ventricular

tachycardia: A prospective, multi-center, single blind, randomize, parallel, investigator initiated study

(CARTO), Johnson & Johnson Medical Korea, Ltd., 2010 - 2013 [Phase IV]

24. Gabapentin versus transdermal fentanyl matrix (TDF) for chronic neuropathic pain (of radicular origin): A multicenter randomized, parallel group, rater blinded, non-inferiority trial, Janssen Korea Ltd., 2010 -

2012 [Phase IV]

25. Conventional monopolar electrosurgery vs. ultrasonically activated shear (HARMONIC), Johnson & Johnson Medical Korea Ltd., 2010 - 2012 [Phase IV]

26. A multicenter trial of oxcarbazepine oral suspension (Trileptal® Oral Suspension) monotherapy in children newly diagnosed with partial seizures, Norvatis Korea Inc., 2009 - 2012 [Phase IV]

27. A randomized, double-blind, active-controlled, parallel group study to compare the efficacy and safety of extended release tramadol HCl/Acetaminophen with immediate release Tramadol

HCl/Acetaminophen in patients with acute, moderate to severe postoperative pain (ULTER-3004),

Janssen Korea Ltd., 2009 - 2012 [Phase III]

28. A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of extended release tramadol HCl/Acetaminophen for the treatment of chronic low-back pain (ULTER-

3003), Janssen Korea Ltd., 2009 - 2010 [Phase IV]

29. A randomized, open-label, multi-center, prospective, non-inferiority trial to compare antihypertensive effect and edema incidence between Lacidipine and Amlodipine in Korean elderly hypertensive patients

(ELDER), GlaxoSmithKline Korea, 2007 - 2010 [Phase IV]

30. A phase IV, multi-center, open label, single arm clinical trial to evaluate the relationship of bone remodeling markers for skeletal complications in metastatic breast cancer patients (ZOMETA), The

Korean Breast Cancer Study Group (KBCSG), 2006 - 2009 [Phase IV]

31. A multicenter, randomized, double blind, placebo-controlled trial to evaluate efficacy and safety of Melsmon Inj. for treating post-menopausal symptom. Korea Melsmon Co., Ltd., 2006 - 2008 [Phase IV]

32. Cilostazol in acute ischemic stroke treatment (CAIST), Korea Otsuka Pharma. Co., Ltd., 2006 - 2008 [Phase IV]

33. The efficacy and safety of testosterone undecanoate (Nebido® ) in testosterone deficiency syndrome in Korean: A multicenter prospective study (NEBIDO), Schering Korea, Ltd., 2005 - 2007 [Phase IV]

34. A non-comparative, single-arm, multicenter phase IV clinical trial of Tamsulosin effects for efficacy and safety of improving sexual dysfunction in patients with prostatism, Astellas Pharma. Korea Inc., 2005 -

2006 [Phase IV]

35. Open, randomized trial for comparing the efficacy and relapse rate of itraconazole pulse therapy with those of terbinafine continuous dosing against onychomycosis, Janssen Korea Ltd., 2004 - 2005 [Phase

IV]

3

[Project] Clinical research (served as a biostatistician-in-charge)

1. Non-Steroidal Anti-Inflammatory Drug adherence and pain control among Osteoarthritis (OA) patients with moderate and severe pain) (NSAID OA), Pfizer Upjohn Korea Limited, 2020 - Designing

2. Study to develop Korean dementia screening test, Ministry of Health and Welfare, Korea Government, 2020 - Current

3. Effects of fenofibrate on diabetic retinopathy in patients with type 2 diabetes (ECLIPSE-REAL 1), Abbott, 2020 - Current

4. Comparative efficacy of fenofibrate and omega 3 fatty acid on cardiovascular outcomes in adults with metabolic syndrome (ECLIPSE-REAL 2), Abbott, 2020 - Current

5. Cardiovascular Disease (CVD) Risk Assessment and Lipid Lowering Treatment in Type 2 Diabetes Mellitus Patients Treated at Secondary and/or Tertiary Hospitals in Korea (CVD risk in T2DM), Pfizer

Upjohn Korea Limited, 2020 - Current

6. A retrospective nationwide analysis of AED prescription pathways of treated epilepsy patients in South Korea (EPILEPSY), 2019 – Current

7. Management and outcomes of stroke patients with atrial fibrillation in the non-VKA oral anticoagulant era (MOVE), Bayer Korea, 2019 - Current

8. Prevalence of the Fabry disease in unselected young patients: A nationwide, multicenter, prospective, registry-based study (FABRY study), Shire Korea, 2018 - Current

9. A prospective, clinical registry for East-Asian ischemic stroke patients with atrial fibrillation (EAST-AF registry), The Clinical Research Center for Stroke – Korea (CRCS-K) registry and The Stroke Acute

Management with Urgent Risk-factor Assessment and Improvement - Non-Valvular Atrial Fibrillation

(SAMURAI-NVAF) registry study, Bristol-Myers Squibb (BMS), 2017 - Current

10. Stroke cohort study for biomarker development (Brain Disease Study), Korea Center for Disease Control (KCDC), 2017 - Current

11. A development of follow-up system to produce nationwide stroke-related statistics and its preliminary implementation (Regional Cardiovascular Center Registry), Korea Center for Disease Control (KCDC),

2017 - Current

12. Adverse event management and quality of life of advanced renal cancer carcinoma patients treated with targeted cancer therapies in Korea (RCC), Pfizer Korea Inc., 2015 - Current

13. An observational study on the risk of disability and subsequent stroke by etiologic subtype of the index event in South Korean patients with minor acute ischaemic stroke or high-risk TIA (CHRONOS),

AstraZeneca, 2019 – 2020

14. Treatment pattern, satisfaction and productivity loss of ankylosing spondylitis patients treated with tumor necrosis factor inhibitor in Korea (AS Satisfaction), Pfizer Korea Inc., 2018 - 2020

15. Big data analysis on treatment patterns and safety events in patients identified as rheumatoid arthritis according to International Statistical Classification of diseases and related health problems (RA SE OR),

Pfizer Korea Inc., 2018 - 2020

16. Study for the investigation of current status and disparities of acute stroke care using adequacy evaluation data (HIRA), Health Insurance Review & Assessment Service, 2017 - 2020

17. The treatment patterns and clinical outcomes in Korean cancer patients with venous thromboembolism (Cancer VTE), Pfizer Korea Inc., 2017 - 2020

18. Real world practice and patient-reported outcomes in uncontrolled hypertension patients in Korea (Uncontrolled HTN), Pfizer Korea Inc., 2014 - 2020

19. Pan-Asia dyslipidemia and hypertension diagnosis and treatment gap assessment (PANDA), Pfizer Korea Inc., 2014 - 2019

20. Cardiovascular risk factors management in asymptomatic diabetic subjects (CV Risk in DM), Pfizer Korea Inc., 2017 - 2018

4

21. Patient-reported outcomes of glaucoma patients (Glaucoma OR), Pfizer Korea Inc., 2017 - 2018

22. An analysis on prescribing patterns of antidepressants for patients with neurological disorders in Korea: Epilepsy, Dementia, Parkinson’s disease and Stroke (SSRI), Pfizer Korea Inc., 2017 - 2018

23. Gastrointestinal risk factors and nonsteroidal anti-inflammatory drug adherence of ankylosing spondylitis patients (AS), Pfizer Korea Inc., 2015 - 2018

24. Epidemiology study of stroke patient with atrial fibrillation (SPAF Neuro), Pfizer Korea Inc., 2014 - 2018

25. Burden of disease of peripheral arterial disease patients (PAD), Pfizer Korea Inc., 2014 - 2018

26. Drug compliance of hypertensive patients with accompanying dyslipidemia (HTN-DYS), Pfizer Korea Inc., 2014 - 2018

27. Epidemiology of invasive fungal infection among allogeneic hematopoietic stem cell transplant recipients in Korea (IFI), Pfizer Korea Inc., 2014 - 2018

28. Epidemiology study of stroke patient with atrial fibrillation – The Korean atrial fibrillation investigation II (KORAF-II), Pfizer Korea Inc., 2014 - 2018

29. The study of gastrointestinal risk factors of rheumatoid arthritis & osteoarthritis patients (RA/OA OR), Pfizer Korea Inc., 2017

30. An evaluation of the Minimal Clinically Important Difference (MCID) for the International Knee Documentation Committee (IKDC) total score used as a primary endpoint in the phase III clinical trial of

INVOSSA™(TISSUEGENE C), Kolong Inc., 2016 - 2017

31. Incidence and risk factors of postoperative pneumonia after cancer surgery in adult patients with selected solid cancer (Cancer POP), Pfizer Korea Inc., 2015 - 2017

32. A descriptive retrospective cohort study of burden of illness in patients with ischaemic stroke or transient ischaemic attacks (TIA) and cardiovascular outcomes (ASTRAZENECA OR): Clinical

Research Center for Stroke – 5th division (CRCS-5) registry of South Korea, Astrazeneca Korea, 2015 -

2017

33. Neuropathic pain in chronic low back pain patients; Korean epidemiological study (NLBP), Pfizer Korea Inc., 2014 - 2017

34. Statin persistence in acute ischemic stroke patients (Stroke Compliance OR), Pfizer Korea Inc., 2016

35. Quality of anticoagulation with warfarin in patient with atrial fibrillation for secondary stroke prevention in Korea (Warfarin TTR), Boehringer Ingelheim Korea, 2015 - 2016

36. Lipid lowering management to decrease coronary vascular disease risk in real world practice (CVD Risk), Pfizer Korea Inc., 2014 - 2016

37. A study of examining management status of breakthrough pain cancer patients, Menarini Korea Inc., 2014 - 2015

38. Epidemiology of stroke prevention in atrial fibrillation – The Korean atrial fibrillation investigation II, Pfizer Korea Inc., 2013 - 2015

39. Excess risks of pneumococcal disease in at‐risk persons, Pfizer Korea Inc., 2014

40. Real world of lipid-lowering therapy in Korean stroke patients (ROLLER KOSTR), Pfizer Korea Inc., 2011 - 2013

41. Investigation on the premature ejaculation perceptions and attitudes, Janssen Korea Ltd., 2010 - 2011

42. Cancer patients pain survey 2010, Korean Society for Hospice and Palliative Care, Janssen Korea Ltd., 2010 - 2011

43. Short and long-term assessment of the patient reported outcome (PRO) of patients with lower urinary symptoms suggestive of benign prostatic hyperplasia and treated with tamsulosin HCl 0.2 mg once daily

for 3 and 12 months in Korea (EMU2007), Astellas Pharma. Korea Inc., 2007 - 2008

5

44. Cancer patients pain survey 2006, Korean Society for Hospice and Palliative Care, Janssen Korea Ltd., 2006 - 2007

45. The effect of blood pressure on early neurological deterioration and prognosis in acute lacunar stroke; multi-center prospective observational study (BLESS), Sanofi-Aventis Korea Co., Ltd., 2004 - 2006

[Project] Clinical Data Management (served as a DM director)

1. A descriptive retrospective cohort study of burden of illness in patients with ischaemic stroke or transient ischaemic attacks (TIA) and cardiovascular outcomes: Clinical Research Center for Stroke –

5th division (CRCS-5) registry of South Korea, Astrazeneca Korea, 2015 - 2017

2. Quality of anticoagulation with warfarin in patient with atrial fibrillation for secondary stroke prevention in Korea, Boehringer Ingelheim Korea, 2015 - 2016

3. The incidence of neutropenia in patients taking Yuclid for prevention of vascular events, Yuyu Pharma. Inc., 2009 - 2016 [PMS]

4. A randomized, double-blind, placebo-controlled phase IV trial for an evaluation of the efficacy of Gliatiline® on post-stroke patients with vascular cognitive impairment no dementia (GLITTER),

Daewoong Co., Ltd., 2010 - 2014 [Phase IV]

[Book / Chapter]

1. 한눈에 알 수 있는 의학통계학 (2020) 4 판, 이준영 역, 범문 에듀케이션 - current

2. 36 장. 주변구조적 모형을 이용한 분석기법, 약물역학 (Pharmacoepidemiology) (2011,04) 박병주,

대한약물역학위해관리학회 엮음. 서울대학교출판문화연구원, ISBN 978-89-521-1144-9

3. 한눈에 알 수 있는 의학통계학 (2007 – 2 판; 2010 – 3 판) 이준영 역, 이퍼블릭

4. 역학, 생물통계학 - 자기학습 길잡이 - (2003) 김순덕, 이준영, 천병철 공역, 아카데미아

5. 보건,의학 통계학 (2001) 이준영, 이은일 공저, 계축문화사

[Grant] 연구 과제 (책임 연구자 / 세부 책임자 / 참여 연구원)

1. 공동연구원. 희귀질환 네트워크 중심 내분비 희귀질환 CDM 다기관 적용 및 검증 치료법 개발

사업단, 한국보건산업진흥원 (2019.4 – 현재)

2. 공동연구원. K-MSTER 암 정밀의료 진단 치료법 개발 사업단, 한국보건산업진흥원 (2017.6 –

현재)

3. 공동연구원. 타겟 유효성/안전성 분석 개인맞춤 임상시험 글로벌선도센터,

임상시험글로벌사업단 (KONECT), 한국보건산업진흥원 (2014.11 – 2019.3)

4. 공동연구원. 국가 기반 빅데이터를 활용한 희귀질환 임상시험 활성화 플랫폼 구축,

임상연구인프라조성사업/첨단융복합 임상시험기술개발, 보건복지부 (2017.4 – 2018.12)

5. 공동연구원. 임상시험 글로벌선도센터, 보건의료연구개발사업, 국가임상시험사업단 (KONECT)

(2012.11 – 2017.3)

6. 연구책임자. 다초점 인공수정체 적합 환자군과 부적합 환자군 여부 평가를 위한 체계적 고찰,

한국알콘㈜ (2016.12 – 2017.8)

7. 연구책임자. 복합성 백내장 환자에서 고식적 백내장 수술 시 개선이 필요한 영역에 대한 체계적

고찰, 한국알콘㈜ (2016.12 – 2017.8)

6

8. 연구책임자. 인보사주 임상 3 상 결과의 임상적 유의성(MCID)을 평가하기 위한 연구,

코오롱생명과학㈜ (2016.12 – 2017.6)

9. 연구책임자. 11 개 권역 심뇌혈관질환센터 등록체계 유지관리 및 모니터링, 경상대학교병원

(2016.7 – 2016.12)

10. 공동연구원. 한국건강분류개발 제 6 차년도 연구용역, 통계청 (2015.7 – 2015.12)

11. 공동연구원. 뇌졸중의 역학-일차예방지침, 발생, 예측 및 질관리 모델의 개발, 뇌졸중

임상연구센터 (CRCS), 한국보건산업진흥원, 보건복지부 (2006.6 – 2015.5)

12. 연구책임자. 진단용 방사선 사용량에 따른 국민 방사선량 평가 연구, 방사선안전과,

식품의약품안전청 (2013.2 – 2013.11)

13. 연구책임자. 국민건강정보 DB 를 활용한 적정 표본설계 및 구축방안 연구, 국민건강보험공단

(2012.5 – 2012.12)

14. 연구책임자. 국내의료방사선 사용량 분석을 위한 웹베이스 DB 구축, 국가 환자선량 저감화

기반연구, 식품의약품안전평가원 (2012.1 – 2012.11)

15. 공동연구원. 국가 건강검진이 질병의 조기 진단과 의료 이용, 건강 결과에 미치는 영향,

국민건강보험공단 (2011.5 – 2011.12)

16. 연구책임자. 의료방사선 사용 자료 통계분석, 식품의약품안전평가원 (2010.7 – 2010.10)

17. 연구책임자. 최적의 체표면적 측정을 위한 통계적 알고리즘 및 전국조사를 위한 통계적 샘플링

디자인, 식품의약품안전청 (2007.9 – 2008.4)

18. 공동연구원. 심뇌혈관질환 감시체계 구축사업, 보건복지부 (2005.8 – 2006.6)

19. 연구책임자. 데이터 마이닝 기법을 활용한 상병 별 산재요양 실태에 대한 연구, 노동부 (2004.11 –

2005.6)

20. 연구책임자. SMPH 측정지표의 신뢰도 및 타당도 평가를 위한 통계적 모형구축 및 프로그램 개발,

암 정복 추진연구 개발사업, 보건복지부 (2003.7 – 2005.6)

21. 연구책임자. 변량모형에서 분위수 산포 도표(QDGs)와 경험적 분위수 산포 도표(EQDGs)를

이용한 실험설계 및 분산성분 추정법들의 전반적인 비교방법 개발, 선도연구자 지원사업,

학술진흥재단 (2003.12 – 2004.11)

22. 공동연구원. 유전체 및 단백체 환경 독성 센터”, 기초과학연구사업, 한국과학재단 (2003.9 –

2004.8)

23. 연구책임자. 오차항이 이분산성을 가지는 일원분류 변량모형에서 F-검정의 유의수준 및

검정력에 관한 모형화, 신진교수연구과제 지원사업, 학술진흥재단 (2002.7 – 2003.6)

7

[Publications] (Peer-reviewed researches only)

(International journal)

1. Park J, Jeong E, Lee J. “The Delirium Observation Screening Scale : A systematic review and meta-analysis of diagnostic test accuracy” Clin Nurs Res 2020 (in print)

2. Jeong E, Park J, Lee J. “Diagnostic test accuracy of the Nursing Delirium Screening Scale: A systematic review and meta-analysis” J Adv Nurs 2020 (online)

3. Kim J-T, Lee JS, …, Lee J, et al. “Effectiveness of adding antiplatelets to oral anticoagulants in patients with acute ischemic stroke with atrial fibrillation and concomitant large artery steno-occlusion” Tran

Stroke Res 2020 (online)

4. Gwak D-S, Park H-K, …, Lee J, et al. “Infarct growth patterns may vary in acute stroke due to large vessel occlusion and recanalization with endovascular therapy” Eur Radiol 2020 (online)

5. Hong K, Hwang H, …, Lee J, et al. “Perspectives on antenatal education associated with pregnancy outcomes: Systematic review and meta-analysis” Women Birth 2020 (online)

6. Kang K-W, Moon H, …, Lee J, et al. “Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab” Ann Hematol 2020;99(7):1493–1503.

7. Kim JY, Lee K-J, …, Lee J, et al. “Acute stroke care in Korea in 2013–2014: National averages and disparities” J Korean Med Sci 2020;35(20):e167.

8. Lee K-J, Kim JY, …, Lee J, et al. “Hospital volume and mortality in acute ischemic stroke patients: Effect of adjustment for stroke severity” J Str Cerebrovasc Dis 2020;29(5):104753.

9. Kim SH, Rhee Y, …, Lee J, et al. “Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study” PLoS ONE 2020;15(5):e0232842.

10. Park H-K, Lee JS, …, Lee J, et al. “Statin therapy in acute cardioembolic stroke with no guidance-based indication” Neurology 2020;94:e1984-e1995.

11. Tanaka K, Koga M, …, Lee J, et al. “Atrial fibrillation-associated ischemic stroke patients with prior anticoagulation have higher risk for recurrent stroke” Stroke 2020;51:1150-1157.

12. Choo J, Yang H-M, …, Lee J, et al. “Effects of the healthy children, healthy families, healthy communities program for obesity prevention among vulnerable children: A cluster-randomized

controlled trial” Int J Environ Res Public Health 2020;17:2895.

13. Kim BJ. Kwon SU, …, Lee J, et al. “Cilostazol versus aspirin in ischemic stroke patients with high-risk cerebral hemorrhage subgroup analysis of the PICASSO Trial” Stroke 2020;51:931-937.

14. Kim JH, Moon H, …, Lee J, et al. “Epidemiology and prognosis of pheochromocytoma/paraganglioma in Korea: A nationwide study based on the National Health Insurance Service” Endocrinol Metab

2020;35:157-164.

15. Lee S-H, Park Y-W, …, Lee J, et al. “Gastrointestinal risk factors and patient-reported outcomes of ankylosing spondylitis in Korea” Int J Rheum Dis 2020;23:342–349.

16. Kim BJ, Park J-M, …, Lee J, et al. “Remote blood pressure monitoring and behavioral intensification for stroke: A randomized controlled feasibility trial” PLoS ONE 2020;15(3):e0229483.

17. Kim S-E, Lee H, …, Lee J, et al. “Three-month modified Rankin scale as a determinant of 5-year cumulative costs after ischemic stroke” Neurology 2020;94:e978-e991.

18. Kim Y-J, Jeong I-K, …, Lee J, et al. “Changes in the Quality of Life in Patients with Type 2 Diabetes Mellitus According to Physician and Patient Behaviors” Diabetes Metab J 2020;44:91-102.

19. Kim JY, Lee K-J, …, Lee J, et al. “Development of stroke identification algorithm for claims data using the multicenter stroke registry database” PLoS ONE 2020;15(2):e0228997.

20. Kim KJ, Jang S, …, Lee J, et al. “Actual causes of death in thyroid cancer patients in Korea: A nationwide case control cohort study” Eur J Endocrinol 2020;182:103-110.

8

21. Lee E-J, Kwon SU. …, Lee J, et al. “Changes in high-density lipoprotein cholesterol and risks of cardiovascular events: A post hoc analysis from the PICASSO trial” J Stroke 2020;22(1):108-118

22. Lee K-J, Kim BJ, …, Lee J, et al. “Effect of heart rate on stroke recurrence and mortality in acute ischemic stroke with atrial fibrillation” Stroke 2020;51:162-169.

23. Park H-K, Kim S-E, …, Lee J, et al. “Quality of acute stroke care in Korea (2008–2014): Retrospective analysis of the nationwide and nonselective data for quality of acute stroke care” Eur Stroke J

2019;4(4):337-346.

24. Kim J-T, Park M-S, …, Lee J, et al. “Comparative effectiveness of dual antiplatelet therapy with aspirin and clopidogrel versus aspirin monotherapy in acute, nonminor stroke. A nationwide, multicenter

registry-based study” Stroke 2019;50:3147-3155.

25. Kang J, Kim BJ, …, Lee J, et al. “Blood pressure variability in subacute stage and risk of major vascular events in ischemic stroke survivors” J Hypertens 2019;37;10:2000-2006.

26. Han K-M, Kim MS, …, Lee J, et al. “Chronic medical conditions and metabolic syndrome as risk factors for incidence of major depressive disorder: A longitudinal study based on 4.7 million adults in South

Korea” J Affective Disorders 2019;257:486–494.

27. Kim CY, Park KH, …, Lee J, et al. “A path analysis of effects of patients’ underlying conditions, treatment satisfaction, and adherence on quality of life among Korea glaucoma patients” J Glaucoma

2019;28:785-789.

28. Kim BJ, Kwon SU, …, Lee J, et al. “Blood pressure variability is associated with white matter lesion growth in intracranial atherosclerosis” Am J Hypertens 2019;32(9):918-924.

29. Jang MU, Kang J, …, Lee J, et al. “In-hospital and post-discharge recovery after acute ischemic stroke: a nationwide multicenter stroke registry-base Study” J Korean Med Sci 2019;34(36):e240.

30. Kim NH, Han KH, …, Lee J, et al. “Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study” BMJ 2019;366:l5125.

31. Park H-S, Kim Y-H, …, Lee J, et al. “Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without

antiplatelet therapy: Results from KORAFII registry” J Arrhythm 2019;35:593-601.

32. Ryu W-S, Schellingerhout D, …, Lee J, et al. “White matter hyperintensity load on stroke recurrence and mortality at 1 year after ischemic stroke” Neurology 2019;93:e578-e589.

33. Jeong H-G, Yoon JS, Lee J, Bae H-J. “Incidence of neutropenia in patients with ticlopidine/Ginkgo biloba extract combination drug for vascular events: A post-marketing cohort study” PLoS One

2019;14(6):e0217723.

34. Oh YS, Lee HJ, …, Lee J, et al. “Long-term clinical outcomes after a percutaneous coronary intervention with a drug-eluting stent in patients with unprotected left main coronary artery disease

excluded from clinical trials” Coronary Artery Dis 2019;30:239–248.

35. Lee KB, Lee J-G, …, Lee J, et al. “The epidemiology of fracture in patients with acute ischemic stroke in Korea” J Korean Med Sci 2019;34(22):e164.

36. Kim D, Park J-M, …, Lee J, et al. “Dual versus mono antiplatelet therapy in large atherosclerotic stroke - A retrospective analysis of the nationwide multicenter stroke registry” Stroke 2019;50:1184-1192.

37. Kim KJ, Choi J, Lee J, et al. “Dipeptidyl peptidase‑4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity‑matched cohort study”

Cardiovasc Diabetol 2019;18:28.

38. Kim J-T, Cho B-H, …, Lee J, et al. “Magnetic resonance imaging versus computed tomography angiography based selection for endovascular therapy in patients with acute ischemic stroke” Stroke

2019;50:365-372.

39. Jang H-S, Choi J, …, Seo W-K, Lee J. “The long-term effect of cancer on incident stroke: A nationwide population-based cohort study in Korea” Front Neurol 2019;10:52.

9

40. Kim J-T, Park M-S, …, Lee J, et al. “Comparative effectiveness of aspirin and clopidogrel versus aspirin in acute minor stroke or transient ischemic attack” Stroke 2019;50:101-109.

41. Kim JY, Kang K, …, Lee J, et al. “Executive summary of stroke statistics in Korea 2018: A report from the Epidemiology Research Council of the Korean Stroke Society” J Stroke 2019;21(1):42-59.

42. Lee S-H, Kim BJ, …, Lee J, et al. “Futile reperfusion and predicted therapeutic benefits after successful endovascular treatment according to initial stroke severity” BMC Neurol 2019;11:1-9.

43. Kim D-E, Park J-H, …, Lee J, et al. “Mapping the supratentorial cerebral arterial territories using 1160 large artery infarcts” JAMA Neurol 2019;76(1):72-80.

44. Chae S-W, Kang J-Y, Lee J, et al. “Effect of structural design on the pullout strength of suture anchors for rotator cuff repair” J Orthop Res 2018;36(12):3318-3327.

45. Oh S, Kim J-S, …, Lee J, et al. “Quality of anticoagulation and treatment satisfaction in patients with non-valvular atrial fibrillation treated with vitamin K antagonist: Result from the Korean Atrial

Fibrillation Investigation II” J Korean Med Sci 2018;33(49):e323.

46. Bae H-J, Heo JH, …, Lee J, et al. “Antithrombotic treatments in patients with acute ischemic stroke and non-valvular atrial fibrillation before introduction of non-vitamin K antagonist oral anticoagulants into

practice in Korea” PLoS One 2018;13(11):e0202803.

47. Ryu W-S, Schellingerhout D, …, Lee J, et al. “Hemispheric asymmetry of white matter hyperintensity in association with lacunar infarction” J Heart Assoc 2018;7:e0106563.

48. Kim NH, Choi J, …, Lee J, Kim SG. “Dipeptidyl peptidase-4 inhibitor use and risk of diabetic retinopathy: A population-based study” Diabet Metab 2018;44:361-367.

49. Kim NH, Lim S, …, Lee J, et al. “Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised

controlled trial” BMJ Open 2018;8:e022448.

50. Park J-M, Kim BJ, …, Lee J, et al. “Intensive blood pressure control may not be safe in subacute ischemic stroke by intracranial atherosclerosis: a result of randomized trial” J Hypertens

2018;36(9):1936–1941.

51. Ju SY, Lee J, Kim DH. “Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis” BMC Geriatr 2018;18:206.

52. Rha S-W, Choi S-H, …, Lee J, et al. “Medical resource consumption and quality of life in peripheral arterial disease in Korea: PAD Outcomes (PADO) Research” Korean Circ J 2018;48(9):813-825.

53. Hong JT, Kim J-H, …, Lee J, et al. “Pharmacological target therapy of neuropathic pain and patient-reported outcomes in patients with chronic low back pain in Korea Results from the NLBP Outcomes

Research” Medicine 2018;97:35(e11919).

54. Kim BJ, Cho Y-J, …, Lee J, et al. “Trajectory Groups of 24-Hour Systolic Blood Pressure After Acute Ischemic Stroke and Recurrent Vascular Events” Stroke 2018;49(8):1836-1842.

55. Jung Y, Lee SJ, Lee J, et al. “Assessment of quality of life and safety in postmenopausal breast cancer patients receiving letrozole as an early adjuvant treatment” J Breast Cancer 2018;21(2):182-189.

56. Kim BJ, Lee E-J, …, Lee J, et al. “Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial”

Lancet Neurol 2018;17(6):509-518.

57. Lee K-J, Lee J, Bae H-J. “Response by Lee et al to letter regarding article, “Predictive value of pulse pressure in acute ischemic stroke for future major vascular events” Stroke 2018;49:e232.

58. Lee K-J, Kim BJ, …, Lee J, et al. “Nationwide estimation of eligibility for endovascular thrombectomy based on the DAWN trial” J Stroke 2018;20(2):277-279.

59. Kim YS, Park M-S, …, Lee J, et al. “Effect of statins on survival following stroke in patients with cancer” Front Neurol 2018;9:205.

10

60. Shin J, Kim DY, Lee J, et al. “Practice patterns in distinguishing between background pain and breakthrough pain during patient education: a Korean physician survey” J Cancer Edu 2018;33(2):284-

292.

61. Lee B, Lee JS, …, Lee J, et al. “Effect of the standardization of diagnostic tests on the prevalence of diabetes mellitus and impaired fasting glucose” J Korean Med Sci 2018;33(10):e81.

62. Lee Y-S, Seo YS, …, Lee J, et al. “Can more aggressive treatment improve prognosis in patients with hepatocellular carcinoma? A direct comparison of the Hong Kong Liver Cancer and Barcelona Clinic

Liver Cancer Algorithms” Gut Liver 2018;12(1):94-101.

63. Jung J, Moon SM, …, Lee J, et al. “Incidence and risk factors of postoperative pneumonia following cancer surgery in adult patients with selected solid cancer: results of “Cancer POP” study” Cancer Med

2018;7(1):261-269.

64. Lee K-J, Kim BJ, …, Lee J, et al. “Predictive value of pulse pressure in acute ischemic stroke for future major vascular events” Stroke 2018;49:46-53.

65. Lim J-S, Noh M, …, Lee J, et al. “A methodological perspective on the longitudinal cognitive change after stroke” Dement Geriatr Cogn Disord 2017;44:311–319.

66. Kim J-H, Hong JT, …, Lee J, et al. “Prevalence of neuropathic pain and patient-reported outcomes in Korean adults with chronic low back pain resulting from neuropathic low back pain” Asian Spine J

2017;11(6):917-927.

67. Ju S-Y, Lee J, Kim D-H. “Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly; A meta-analysis of prospective cohort studies” Medicine

2017;96(45):e8491.

68. Park H-K, Kim BJ, …, Lee J, et al. “One-year outcomes after minor stroke or high-risk transient ischemic attack - Korean multicenter stroke registry analysis” Stroke 2017;48:2991-2998.

69. Shon S-M, Jang HJ, …, Lee J, et al. “Cytokine response to diet and exercise affects atheromatous matrix metalloproteinase-2/9 activity in mice” Circ J 2017;81:1528–1536.

70. Choi J-K, Chi S-Y, …, Lee J, et al. “Epidemiology and risk factors for invasive fungal diseases among allogeneic 1 hematopoietic stem cell transplant recipients in Korea: Results of “RISK” study” Biol Blood

Marrow Transplant 2017;23(10):1773-1779.

71. Lim J-S, Kwon H-M, …, Lee J, et al. “Effects of temperature and pressure on acute stroke incidence assessed using a Korean nationwide insurance database” J Stroke 2017;19(3):295-303

72. Hong K-S, Kim Y-K, …, Lee J, et al. “Quality of anticoagulation with warfarin in Korean patients with Atrial fibrillation and prior stroke: A multicenter retrospective observational study” J Clin Neurol

2017;13(3):273-280.

73. Choi JC, Kim BJ, …, Lee J, et al. “Utility of items of baseline national institutes of health stroke scale as predictors of functional outcomes at three months after mild ischemic stroke” J Stroke Cerebrovasc Dis,

2017;26(6):1306–1313.

74. Park J-H, Lee J, Ovbiagele B. “Association of optimal combination drug treatment with obesity status among recent ischemic stroke patients: Results of the Vitamin Intervention for Stroke Prevention (VISP)

Trial” J Stroke 2017;19(2):213-221.

75. Kim GH, Shin SW, Lee J, et al. “Red meat and chicken consumption and its association with high blood pressure and obesity in South Korean children and adolescents: a cross-sectional analysis of KSHES,

2011–2015” Nutrit J 2017;16(31):1-10.

76. Lee HJ, Lee JS, …, Lee J, et al. “Simple estimates of symptomatic intracranial hemorrhage risk and outcome after intravenous thrombolysis using age and stroke severity” J Stroke 2017;19(2):229-231.

77. Kim YJ, Lee JS, …, Lee J, et al. “Trends in socioeconomic inequalities in five major risk factors for cardiovascular disease in the Korean population: a cross-sectional study using data from the Korea

National Health and Nutrition Examination Survey, 2001–2014” BMJ Open 2017;0:e014070.

11

78. Lee J, Lee JS, Park S-H, Shin SA, Kim KW. “Cohort Profile: The National Health Insurance Service – National Sample Cohort (NHIS-NSC), South Korea” Int J Epidemiol 2017;e15:1-8.

79. Park H-K, Chung J-W, …, Lee J, et al. “Preceding intravenous thrombolysis in patients receiving endovascular therapy” Cerebrovasc Dis 2017;44:51–58.

80. Chung J-W, Kim JY, …, Lee J, et al. “Impact of the penumbral pattern on clinical outcome in patients with successful endovascular revascularization” J Stroke Cerebrovasc Dis 2017;26(2):360-367.

81. Chung J-W, Bang OY, …, Lee J, et al. “Air pollution is associated with ischemic stroke via cardiogenic embolism” Stroke 2017;48:17-23.

82. Kim J-T, Park M-S, …, Lee J, et al. “Clinical outcomes of posterior versus anterior circulation infarction with low National Institutes of Health Stroke Scale scores” Stroke 2017;48:55-62.

83. Ryu W-S, Woo S-H, …, Lee J, et al. “Stroke outcomes are worse with larger leukoaraosis volumes” Brain 2017;140:158-170.

84. Hong J-H, Sohn S-I, …, Lee J, et al. “Endovascular treatment in patients with persistent internal carotid artery occlusion after intravenous tissue plasminogen activator: A clinical effectiveness study”

Cerebrovasc Dis 2016;42:387-394.

85. Park M-S, Lee JS, …, Lee J, et al. “Characteristics of the drip-and-ship paradigm for patients with acute ischemic stroke in South Korea” J Stroke Cerebrovasc Dis 2016;25(11):2678-2687.

86. Ryu H, Kim Y, Lee J, et al. “Office workers’ risk of metabolic syndrome-related indicators: A 10-year cohort study” Western J Nursing Res 2016;38(11):1433-1447.

87. Lee S-H, Kim BJ, …, Lee J, et al. “Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?” Int J Stroke 2016;11(7):783-790.

88. Choi JC, Lee JS, …, Lee J, et al. “Prestroke antiplatelet effect on symptomatic intracranial hemorrhage and functional outcome in intravenous thrombolysis” J Stroke 2016;18(3):344-351.

89. Yu K-H, Hong K-S, …, Lee J, et al. “Design and rationale for a cognitive outcome substudy in ischemic stroke patients with high risk of cerebral hemorrhage” J Stroke Cerebrovasc Dis 2016;25(8):2061-2066.

90. Chung J-W, Kim BJ, …, Lee J, et al. “Family history and risk of recurrent stroke” Stroke 2016;47(6):1990-1996.

91. Chung J-W, Kim BJ, …, Lee J, et al. “Impact of guidelines on clinical practice - Intravenous heparin use for acute ischemic stroke” Stroke 2016;47(6):1577-1583

92. Chae S-W, Lee H, …, Lee J, et al. “Primary stability of inferior tilt fixation of the glenoid component in reverse total shoulder arthroplasty: A finite element study” J Orthop Res 2016;34:1061-1068.

93. Oh MS, Yu K-H, …, Lee J, et al. “Aspirin resistance is associated with increased stroke severity and infarct volume” Neurology 2016;86:1808-1817.

94. Kim D-H, Bae H-J, …, Lee J, et al. “Direct admission to stroke centers reduces treatment delay and improves clinical outcome after intravenous thrombolysis” J Clin Neurosci 2016;27:74-79.

95. Baek SK, Kim DY, …, Lee J, et al. “A Korean nationwide survey for breakthrough cancer pain in an inpatient setting” Cancer Res Treat 2016;48(2):768-774.

96. Park J-M, Kang K, …, Lee J, et al. “Comparative effectiveness of prestrike aspirin on stroke severity and outcome” Ann Neurol 2016;79:560-568.

97. La SA, Lee J, et al. “Low magnesium levels in adults with metabolic syndrome: a meta-analysis” Biol Trace Elem Res 2016;170:33-42.

98. Kang K, Park TH, …, Lee J, et al. “Recurrent stroke, myocardial infarction, and major vascular events during the first year after acute ischemic stroke: The multicenter prospective observational study about

recurrence and its determinants after acute ischemic stroke I” J Stroke Cerebrovasc Dis 2016;25(3):656-

664.

12

99. Kim W-J, Park J-M, …, Lee J, et al. “Adherence to guidelines for antithrombotic therapy in patients with atrial fibrillation according to CHADS2 score before and after stroke: A multicenter observational

study from Korea” J Clin Neurol 2016;12(1):34-41.

100. Kim J-T, Park M-S, …, Lee J, et al. “Different antiplatelet strategies in patients with new ischemic stroke while taking aspirin” Stroke 2016;47:128-134.

101. Kang J, Jung C, …, Lee J, et al. “A simple geometric assessment of perfusion lesion volume at hyperacute stage of ischemic stroke in patients with symptomatic steno-occlusion of major cerebral

arteries and risk of subsequent cerebral ischemic events” J Stroke Cerebrovasc Dis 2015;24(12):2669-

2675.

102. Lee SJ, Cho Y-J, …, Lee J, et al. “Moderate alcohol intake reduces risk of ischemic stroke in Korea” Neurology 2015;85:1950-1956.

103. Kim KW, Lee J, et al. “Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: A practical review for clinical researchers–Part I. General guidance and tips” Korean J Radiol

2015;16(6):1175-1187.

104. Lee J, Kim KW, et al. “Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: A practical review for clinical researchers–Part II. Statistical methods of meta-analysis”

Korean J Radiol 2015;16(6):1188-1196.

105. Chung J-W, Kim N, …, Lee J, et al. “Blood pressure variability and the development of early neurological deterioration following acute ischemic stroke” J Hypertens 2015;33(10):2099-2106.

106. Kim NH, Lee J, et al. “Body mass index and mortality in the general population and in subjects with chronic disease in Korea: A nationwide cohort study (2002-2010)” PLoS ONE 2015;10(10):e0139924.

107. Hong K-S, Kim BJ, Lee J, et al. “Rationale and design of the prevention of cardiovascular events in ischemic stroke patients with high risk of cerebral hemorrhage (PICASSO) study: A randomized

controlled trial” Int J Stroke 2015;10(7):1153-1158.

108. Park TH, Ko Y, …, Lee J, et al. “Identifying target risk factors using population attributable risks of ischemic stroke by age and sex” J Stroke 2015;17(3):302-311.

109. Choi JC, Lee JS, …, Lee J, et al. “Intravenous tissue plasminogen activator improves the outcome in very elderly Korean patients with acute ischemic stroke” J Stroke 2015;17(3):327-335.

110. Kim BJ, Han M-K, …, Lee J, et al. “Low-versus standard-dose alteplase for ischemic strokes within 4.5 hours; A comparative effectiveness and safety study” Stroke 2015;46:2541-2548.

111. Lee S-H, Kim KS, …, Lee J, et al. “Risk factors and incidence of falls among fifth- and sixth-grade children in Seoul, South Korea” Southeast Asian J Tropic Med Public Health 2015;46(5):924-938.

112. Kang J, Kim N, …, Lee J, et al. “Early statin use in ischemic stroke patients treated with recanalization therapy: retrospective observational study” BMC Neurol 2015;15:122.

113. Choi JC, Lee JS, …, Lee J, et al. “Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study” BMC Neurol 2015;15:120.

114. Oh MS, Yu K-H, …, Lee J, et al. “Modest blood pressure reduction with valsartan in acute ischemic stroke: a prospective, randomized, open-label, blinded–end-point trial” Int J Stroke 2015;10:745-753.

115. Chae SW, Lee J, et al. “Inferior tilt fixation of the glenoid component in reverse total shoulder arthroplasty: A biomechanical study” Orthop & Traumatol: Surgery & Res 2015;101(4):421–425.

116. Lee JS, Kim CK, …, Lee J. “A novel computerized clinical decision support system for treating thrombolysis in patients with acute ischemic stroke” J Stroke 2015;17(2):199-209.

117. Kim BJ, Han M-K, …, Lee J, et al. “Trends in the effectiveness of endovascular recanalization for acute stroke: Is a change taking place?” J Stroke Cerebrovasc Dis 2015;24(4):866-873.

118. Kim BJ, Park J-M, …, Lee J, et al. "Case characteristics, hyperacute treatment, and outcome information from the Clinical Research Center for Stroke–fifth division registry in South Korea" J Stroke

2015;17(1):38-53.

13

119. Choi JC, Jang MU, …, Lee J, et al. “Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke” J Am Heart Assoc 2015;4:e001306.

120. Chae S-W, Kim S-Y, …, Lee J, et al. “Effect of baseplate size on primary glenoid stability and impingement-free range of motion in reverse shoulder arthroplasty” BMC Musculoskeletal Disorders

2014;15(417):1-7.

121. Ryu W-S, Woo S-H, …, Lee J, et al. “Grading and interpretation of white matter hyperintensities using statistical maps” Stroke 2014;45:3567-3575.

122. Park J-M, Cho Y-J, …, Lee J, et al. “Internet-based control recruitment for a case–control study of major risk factors for stroke in Korea: lessons from the experience” J Stroke Cerebrovasc Dis

2014;23(10):2559-2565.

123. Park J-H, Lee J, Ovbiagele B. “Nontraditional serum lipid variables and recurrent stroke risk” Stroke 2014;45(11):3269-3274.

124. Ko Y, Lee SJ, …, Lee J, et al. "MRI-based algorithm for acute ischemic stroke subtype classification" J Stroke 2014;16(3):161-172.

125. Hong J-H, Kang J, …, Lee J, et al. “Recanalization therapy for internal carotid artery occlusion presenting as acute ischemic stroke” J Stroke Cerebrovasc Dis 2014;23(8):2183-2189.

126. Park TH, Ko Y, …, Lee J, et al. “Gender differences in the age-stratified prevalence of risk factors in Korean ischemic stroke patients: a nationwide stroke registry-based cross-sectional study” Int J Stroke

2014;9:759-765.

127. Park TH, Lee JS, …, Lee J, et al. “Safety and efficacy of intravenous recombinant tissue plasminogen activator administered in the 3- to 4.5-hour window in Korea” J Stroke Cerebrovasc Dis

2014;23(7):1805-1812.

128. Choo J, Lee J, et al. “Effects of weight management by exercise modes on markers of subclinical atherosclerosis and cardiometabolic profile among women with abdominal obesity: a randomized

controlled trial” BMC Cardiovasc Dis 2014;14(82):1-13.

129. Lee DR, Lee J, …, Lee J, et al. “Coffee consumption and risk of fractures: A systematic review and dose–response meta-analysis” Bone 2014;63:20-28.

130. Kim BJ, Han M-K, …, Lee J, et al. “Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry” Int J Stroke 2014;9(4):514-518.

131. Jang MU, Hong J-H, …, Lee J, et al. “Current status of recanalization therapy in acute ischemic stroke with symptomatic intracranial arterial occlusion in Korea” J Stroke Cerebrovasc Dis 2014;23(5):e339-

e346.

132. Kwon H-M, Oh MS, …, Lee J, et al. "Physicians’ attitudes toward guidelines for stroke: A survey of Korean neurologists" J Stroke 2014;16(2):81-85.

133. Kang J, Kim N, …, Lee J, et al. “Symptomatic steno-occlusion of cerebral arteries and subsequent ischemic events in patients with acute ischemic stroke” J Stroke Cerebrovasc Dis 2014;23(5):e347-e353.

134. Kim DY, Ahn JS, …, Lee J, et al. “A nationwide survey of knowledge of and compliance with cancer pain management guidelines by Korean physicians” Cancer Res Treat 2014;46(2):131-140.

135. Lim J-S, Kim N, …, Lee J, et al. “Cortical hubs and subcortical cholinergic pathways as neural substrates of poststroke dementia” Stroke 2014;45(4):1069-1076.

136. Kim S-Y, Chae S-W, Lee J. “Effect of Poloxamer 407 as a carrier vehicle on rotator cuff healing in a rat model” J Orthop Surgery Res 2014;9(12):1-9.

137. Park TH, Park S-S…, Lee J, et al. “The iScore predicts clinical response to tissue plasminogen activator in Korean stroke patients” J Stroke Cerebrovasc Dis 2014;23(2):367-373.

138. Choo J, Jeon S, Lee J. “Gender differences in health-related quality of life associated with abdominal obesity in a Korean population” BMJ Open 2014;4:e003954.

14

139. Kang J, Park TH, …, Lee J, et al. "Symptomatic steno-occlusion in patients with acute cerebral infarction: prevalence, distribution, and functional outcome" J Stroke 2014;16(1):36-43.

140. Lee J, Choi YS, …, Lee J, et al. “Poor-quality sleep is associated with metabolic syndrome in Korean adults” The Tohoku J Experiment Med 2013;231(4):281-291.

141. Hong K-S, Lee J, et al. “Greater stroke severity predominates over all other factors for the worse outcome of cardioembolic stroke” J Stroke Cerebrovasc Dis 2013;22(8):e373-e380.

142. Park YH, Kim BJ, …, Lee J, et al. “Impact of both ends of the hemoglobin range on clinical outcomes in acute ischemic stroke” Stroke 2013;44:3320-3222.

143. Hong K-S, Oh MS, …, Lee J, et al. “Statin prescription adhered to guidelines for patients hospitalized due to acute ischemic stroke or transient ischemic attack” J Clin Neurol 2013;9:214-222.

144. Thabane L, Mbuagbaw L, …, Lee J, et al. “A tutorial on sensitivity analyses in clinical trials: the what, why, when and how” BMC Med Res Meth 2013;13(92):1-12.

145. Park TH, Saposnik G, …, Lee J, et al. “The iScore predicts functional outcome in Korean patients with ischemic stroke” Stroke 2013;44:1440-1442.

146. Park TH, Hong K-S, …, Lee J, et al. “Validation of minor stroke definitions for thrombolysis decision making” J Stroke Cerebrovasc Dis 2013;22(4):482-490.

147. Park J-M, Koo J-S, …, Lee J, et al. “Vertebrobasilar dolichoectasia as a risk factor for cerebral microbleeds” Eur J Neurol 2013;20:824-830.

148. Park J-H, Hong K-S, Lee J, et al. “Deep subcortical infarct burden in relation to apolipoprotein B/AI ratio in patients with intracranial atherosclerotic stenosis” Eur J Neurol 2013;20:671-680.

149. Eun M-Y, Seo W-K, Lee J, et al. “Age-dependent predictors for recurrent stroke: The paradoxical role of triglycerides” Eur Neurol 2013;69:171-178.

150. Chung J-W, Kim KJ, …, Lee J, et al. “Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue

plasminogen activator” Cerebrovasc Dis 2013;35:461-468.

151. Eun S-H, Kim HD, …, Lee J, et al. “A multicenter trial of oxcarbazepine oral suspension monotherapy in children newly diagnosed with partial seizures: A clinical and cognitive evaluation” Seizure

2012;21:679-684.

152. Kang J, Ko Y, …, Lee J, et al. “Effect of blood pressure on 3-month functional outcome in the subacute stage of ischemic stroke” Neurology 2012;79(20):2018-2024.

153. Kim BJ, Oh M-Y, …, Lee J, et al. “Medial Temporal Atrophy and Memory Dysfunction in Poststroke Cognitive Impairment-No Dementia” J Clin Neurol 2012;8(1):43-50.

154. Park JH, Ko Y, …, Lee J, et al. “Is asymptomatic hemorrhagic transformation really innocuous?” Neurology 2012;78(6):421-426.

155. Rho S-Y, Choi J-I, Lee J, et al. “Catheter ablation of atrial fibrillation in patients with chronic lung disease” Circulation – Arrhythm Electrophysiol 2011;4(6):815-822.

156. Park J-H, Hong K-S, …, Lee J, et al. “High levels of apolipoprotein B/AI ratio are associated with intracranial atherosclerotic stenosis” Stroke 2011;42:3040-3046.

157. Yoon YK, Lee SE, Lee J, et al. “Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case–control study” J Antimicrob

Chemother 2011;66(8):1831-1838.

158. Hong K-S, Kim J, …, Lee J, et al. “Burden of ischemic stroke in Korea: Analysis of disability-adjusted life years lost” J Clin Neurol 2011;7:77-84

159. Hong K-S, Yegiaian S, …, Lee J, et al. “Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design” Circulation

2011;123:2111-2119.

15

160. Kim BJ, Lee S-H, …, Lee J, et al. “Paradoxical longevity in obese patients with intracerebral hemorrhage” Neurology 2011;76:567-573.

161. Ko Y, Park JH, …, Lee J, et al. “The significance of blood pressure variability for the development of hemorrhagic transformation in acute ischemic stroke” Stroke 2010;41:2515-2518.

162. Kim DH, Kim JA, …, Lee J, et al. “Heart rate variability and length of survival in hospice cancer patients” J Korean Med Sci 2010;25:1140-1145.

163. Jeong N-H, Lee J-M, …, Lee J, et al. “Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women” Gynecol Oncol 2010;118:24-28.

164. Moon DG, Park MG, …, Lee J, et al. “The efficacy and safety of testosteron undecanoate (NEVIDO) in testosteron deficiency syndrome in Korean: A multicenter prospective study” J Sexual Med

2010;7:2253-2260.

165. Kim W-J, Ko Y, …, Lee J, et al. “Differential effect of previous antiplatelet use on stroke severity according to stroke mechanism” Stroke 2010;41:1200-1204.

166. Lee S-H, Kim BJ, …, Lee J, et al. “Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study” Diabetologia 2010;53:429-434.

167. Ko S-B, Choi SI, …, Lee J, et al. “Role of cardiac multidetector computed tomography in acute ischemic stroke: A preliminary report" Cerebrovasc Dis 2010;29:313-320.

168. Jung W-W, Phark S, …, Lee J, et al. “Analysis of low molecular weight plasma proteins using ultrafilteration and large gel two-dimensional electrophorosis” Proteomics 2009;9:1827-1840.

169. Cho S-H, Lee J-S, Tabane L, Lee J. “Acupuncture for obesity: a systematic review and meta-analysis” Int J Obes 2009;33:183-196.

170. Kim SH, Choi YS, Lee J, et al. “Reliability and validity of the hospice quality of life scale for Korean cancer patients” J Pain Sympt Manag 2009;37(2):156-167.

171. Kim SH, Seo BK, Lee J, et al. “Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer” Acta Oncologica 2008;47:1531-1538.

172. Cho KR, Seo BK, Lee J, et al. “A comparative study of palpable and nonpalpable breast cancers determined by ultrasonography” J Breast Cancer 2008;11(2):64-70.

173. Jung BC, Khuri AI, Lee J. “Comparison of designs for the three-fold nested random model” J Appl Statist 2008;35(6):701-715.

174. Seo JA, Kim NH, …, Lee J, et al. “Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease” Clin Endocrinol 2008;68:555-560.

175. Bae HJ, Lee J, et al. “Risk factors of intracranial cerebral atherosclerosis among asymptomatics” Cerebrovasc Dis 2007;24:355-360.

176. Lee J, Khuri AI, et al. “On the size of the F-test for the one-way random model with heterogeneous error variances” J Statist Comput Simul 2007;77(6):443-455.

177. Choi KM, Kim SM, …, Lee J. “Prevalence and cardiovascular disease risk of the metabolic syndrome using NCEP and IDF definitions in the Korean population” Metab Clin Exp 2007;56(4):552-558.

178. Kim JA, Kim SM, …, Lee J, et al. “The prevalence and risk factors associated with isolated untreated systolic hypertension in Korea: The Korean National Health and Nutrition Survey 2001” J Human

Hypertens 2007;21:107-113.

179. Park HS, Kim SM, …, Lee J, et al. “Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001” Diab, Obes Metab 2007;9:50-58.

180. Ju YJ, Lee KH, …, Lee J, et al. “Decreased expression of DNA repair proteins KU70 and Mre11 is associated with aging and may contribute to the cellular senescence” Exp Mol Med 2006;38(6):686-693.

181. Seo BK, Pisano ED, …, Lee J, et al. “Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas” Academ Radiol 2006;13(10):1211-1218.

16

182. Seo BK, Pisano ED, …, Lee J, et al. “The positive predictive value for diagnosis of breast cancer: Full-field digital mammography versus film-screen mammography in the diagnostic mammographic

population” Academ Radio 2006;13(10):1229-1235.

183. Choi KM, Park HS, …, Lee J, et al. “Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001” J Hypertens 2006;24:1515-1521.

184. Ham BJ, Lee YM, …, Lee J, et al. “Personality, dopamine receptor D4 Exon III polymorphisms, and academic achievement in medical students” Neuropsychobiology 2006;53:203-209.

185. Park SS, Park JM, …, Lee J, et al. “Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?” J Surg Oncol 2006;94:16-20.

186. Kim KU, Yoon SJ, Lee J, et al. “Validation of the Korean version of the McMaster quality of life scale in terminal cancer patients” J Palliat Care 2006;22(1):40-45.

187. Choi YS, Kim SH, …, Lee J, et al. “Change in the patients' satisfaction with pain control after using the Korean Cancer Pain Assessment Tool in Korea” J Pain Sympt Manag 2006;31(6):553-562.

188. Yoon SZ, Shin TJ, …, Lee J, et al. “Depth of a central venous catheter tip: length of insertion guideline for pediatric patients” Acta Anaesthesiol Scand 2006;50:355-357.

189. Lee HM, Baek SK, …, Lee J, et al. “Cyclooxygenase 1 and 2 expressions in the human thyroid gland” Eur Arch Oto-Rhino-Laryngol Head & Neck 2006;263:199-204.

190. Kim SG, Ryu OH, …, Lee J, et al. “Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or non-diabetic metabolic syndrome” Eur J Endocrinol

2006;154:433-440.

191. Ryu OH, Lee J, et al. “Effects of green tea consumption on inflammation insulin resistance and pulse wave velocity in type 2 diabetes patients” Diab Res Clin Pract 2006;71:356-358.

192. Bae HJ, Yoon BW, …, Lee J, et al. “Correlation of coronary and cerebral atherosclerosis: Difference between extracranial and intracranial arteries” Cerebrovasc Dis 2006;21:112-119.

193. Kim SM, Lee JS, Lee J, et al. “Prevalence of diabetes and impaired fasting glucose in Korea” Diab Care 2006;29:226-231.

194. Ahn HS, Yoon SJ, …, Lee J, et al. “Association between unplanned readmission rate and volume of breast cancer operation cases” Int J Clin Prac 2006;60(1):32-35.

195. Kim M, Bae HJ, Lee J, et al. “Apolipoprotein E2/E4 polymorphism and cerebral microbleeds on gradient echo MRI” Neurology 2005;65:1474-1475.

196. Choi CW, Lee J, et al. “Incidence of anemia in older Koreans: Community-based cohort study” Arch Gerontol Geriatr 2005;41:303-309.

197. Bae HJ, Yoon DS, Lee J, et al. “In-hospital medical complications and long-term mortality after ischemic stroke” Stroke 2005;36:2441-2445.

198. Cho KR, Seo BK, Lee J, et al. “A comparative study of 2D and 3D ultrasonography for evaluation of solid breast masses” Eur J Radiol 2005;54:365-370.

199. Lee J, Khuri AI, Kim KW. “Modeling the coverage probability of a confidence interval on the among-group variance component in the unbalanced random one-way model” Comput Statist 2005;20:275-294.

200. Choi CW, Cho WR, …, Lee J. “The cutoff value of serum ferritin for the diagnosis of iron deficiency in community-residing older persons” Ann Hematol 2005;84:172-178.

201. Seo BK, Pisano ED, …, Lee J, et al. “Low-dose multidetector dynamic CT in the breast Preliminary study” J Clin Imag 2005;29:172-178.

202. Lee YJ, Shin KS, …, Lee J, et al. “Association of the oestrogen receptor-alpha gene polymorphisms with disease onset in systemic lupus erthematosus” Ann Rheum Dis 2004;63:1244-1249.

203. Lee E, Oh E, Lee J, Sul D, Lee J. “Use of the tail moment of the lymphocytes to evaluate DNA damages in human biomonitoring studies” Toxicol Sci 2004;81:121-132.

17

204. Choi KM, Lee J, et al. “Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans” Clin Endocrinol 2004;61:75-80.

205. Choi KM, Lee J, et al. “The associations between plasma adiponectin, ghrelin levels, and cardiovascular risk factors” Eur J Endocrinol 2004;150:715-718.

206. Choi KM, Lee J, et al. “Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance” Diab Res

Clin Pract 2004;64:99-106.

207. Choi CW, Lee J, et al. “Prevalence and characteristics of anemia in the elderly: cross-sectional study of three urban Korean population samples” Am J Hematol 2004;77:26-30.

208. Woo JS, Baek SK, …, Lee J. “T3 supraglottic cancer: treatment result and prognostic factors” Acta Otolaryngol 2003;123:980-986.

209. Choi KM, Lee J, et al. “Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul(SWS) Study” Diab Res Clin Pract 2003;60:205-212.

210. Khuri AI, Lee J. “Quantile dispersion graphs for comparing designs for random ANOVA models” In: Proc Graybill Conf, 2001, on Linear, Nonlinear, and Generalized Linear Models, Colorado State

University, Fort Collins, Colorado 80523, 2003;227-240.

211. Lee J. “The effect of design imbalance on the power of the F-test of a variance component in the one-way random model” Biomet J 2003; 45(2): 238-248.

212. Choi KM, Lee J, et al. “Factor analysis of the metabolic syndrome among elderly Koreans - the South-west Seoul Study” Diab Med 2003;20:99-104.

213. Choi KM, Lee J, et al. “Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans” Diab Med 2002;19:853-857.

214. Lee J, Khuri AI. “Comparison of confidence intervals on the among-group variance component for the unbalanced one-way random model” Commun Statist - Simul Comput 2002;31:35-37.

215. Seo BK, Oh YW, …, Lee J, et al. “Sonographic evaluation of breast nodules comparison of conventional, real-time compound, and pulse inversion harmonic images” Korean J Radiol 2002;3(1):38-44. (English)

216. Lee J, Khuri AI. “Modeling the probability of a negative ANOVA estimate of a variance component” Calcutta Statist Assoc Bullet 2001;31-45.

217. Lee J, Khuri AI. “Quantile dispersion graphs for the comparison of designs for a random two-way model” J Statist Plan Inf 2000;91:123-137.

218. Lee J, Khuri AI. “Graphical technique for comparing designs for random models” J App Statist 1999;26(8):933-947.

219. Khuri AI, Lee J. “A Graphical approach for evaluating and comparing designs for nonlinear models” Comput Statist Data Anal 1998;27:433-443.

18

(Domestic journal)

1. 박윤아, …, 이준영 등 “주요 신경계질환의 항우울제 처방 패턴: 2017 년 제도 변경 이전”, Journal

of Korean Neurological Association, 2019;37(2):156-160.

2. 김정원, …, 이준영. “항생제 투약이 호스피스 환자의 삶의 질에 미치는 효과: 일개 상급 종합병원

완화의료병동 환자를 대상으로”, Korean Journal of Family Practice, 2016;6(1):20-25.

3. 정지훈, …, 이준영 등. “마약성 진통제 사용과 Cortisol 및 DHEAS 와의 관계”,

한국호스피스완화의료학회지, 2015;18(2):105-111.

4. 최선영, …, 이준영. “말기암환자에서 혈중 비타민 D 농도와 생존기간과의 관련성”,

한국호스피스완화의료학회지, 2015;18(2):120-127.

5. 이수희, …, 이준영. “말기암환자에서 예후인자로서 혈청 Ferritin 의 유용성”,

한국호스피스완화의료학회지, 2015;18(1):51-59.

6. 이진아, …, 이준영. “말기암환자에서 혈장 내독소 농도가 생존기간에 미치는 영향”,

한국호스피스완화의료학회지, 2014;17(2):57-65.

7. 이소진, …, 이준영. “말기암환자의 혈중 Visfatin 농도와 식욕부진의 관계”,

한국호스피스완화의료학회지, 2014;17(1):18-26.

8. Park IB, …, Lee J, et al. “Diabetes epidemics in Korea: Reappraise nationwide survey of diabetes ‘Diabetes in Korea 2007’” Diabetes & Metabolism Journal 2013;37:233-239. (In English)

9. Park JH, …, Lee J, et al. “Impact of post-stroke cognitive impairment with no dementia on health-related quality of life” Journal of Stroke 2013;15(1):49-56. (In English)

10. 이지성, 이준영 등 “급성허혈뇌졸중에서 혈전용해치료의 유효성과 안전성에 관한 예후모형

개발”, 대한신경과학회지 2012;30(2):100-109.

11. 홍지현, …, 이준영. "말기암환자의 여명 예측 요인, 혈중 렙틴 농도의 효과",

한국호스피스완화의료학회지 2012;15(2):99-107.

12. 서의경, 이준영 등. "측두하악장애의 유병률과 관련요인에 관한 연구 - 일부 일반사무직,

서비스직, 교직원을 대상으로 -", 한국치위생학회지 2012;12(3):563-576.

13. Kim W-J, …, Lee J, et al. “Effectiveness and Safety of Thrombolysis in Ischemic Stroke Patients Aged 80 Years or Older” Korean Journal of Stroke 2012;14(1):19-28. (In English)

14. 신혜원, 이준영, 안형진. “대응 짝 비열등성 임상시험에서 모의실험을 통한 ITT 군과 PP 군의

비교”, 한국보건정보통계학회지 2011;36(2):217-228.

15. 이지성, …, 이준영. “한국인을 위한 뇌졸중 발생 예측모형 개발”, 대한신경과학회지

2010;28(1):13-21.

16. Park J-H, …, Lee J, et al. “Does smoking increase a risk of hemorrhage transformation in acute ischemic stroke?” Korean Journal of Stroke 2009;11:130-135. (In English)

17. 이지성, …, 이준영. “우리나라 당뇨병의 역학적 규모와 당뇨병 관리현황 파악을 위한 표본설계의

평가”, 예방의학회지 2009;42(2);135-142.

18. 박태환, …, 이준영 등. “한국인에서 허혈성 뇌졸중 위험 인자의 유병률에 대한 체계적 문헌 고찰”,

대한신경과학회지 2009;27(1):19-27.

19. 이준영. "메타분석", 대한내분비학회지 2008;23(6):361-378.

20. 박태환, …, 이준영 등. "한국인에서 허혈성 뇌졸중에 대한 주요 위험인자들의 인구기여위험도",

대한뇌졸중학회지 2008;10:125-133.

21. 유소연, 이준영, 윤석준 등. “종합병원 정기 건강검진 이행여부와 관련된 요인에 관한 연구”,

자료분석학회지 2008;10(1):119-131.

19

22. 이상희, …, 이준영 등. “서울 경기 지역 양계농가에서 vanA 형 반코마이신 내성 자구균의

분리율과 역학조사”, 대한병원감염관리학회지 2007;12(2):77-84.

23. 강지훈, …, 이준영 등. “두개내 동맥경화증이 뇌경색 이후의 장기 사망률에 미치는 영향”,

대한신경과학회지 2007;25(4):462-468.

24. 김세윤, …, 이준영 등.“간경변 환자에서 CTP, MELD, MELD-Na 점수의 단기 사망률 예측에 대한

비교 분석”, 대한소화기학회지 2007;50(2):81-89.

25. 박석원, …, 이준영 등. “전국표본조사에 의한 우리나라 당뇨병 관리실태: 건강보험자료

분석결과”, 대한당뇨병학회지 2007;31(4):362-367.

26. 이주현, …, 이준영 등. “일부 한국 성인 남성 흡연자들의 림프구 DNA 손상의 증가”,

예방의학회지 2007;40(1):16-22.

27. 김대중, …, 이준영 등. “우리나라 당뇨병성 말기 신부전증의 현황: 건강보험자료 분석결과”,

대한당뇨병학회지 2006;30(5):355-362.

28. 박이병, …, 이준영 등. “당뇨병환자에서 아스피린 사용현황 및 동반질환: 건강보험자료

분석결과”, 대한당뇨병학회지 2006;30(5):363-371.

29. 정춘희, …, 이준영 등. “우리나라 당뇨병성 족부질환의 현황: 건강보험자료 분석결과”,

대한당뇨병학회지, 2006;30(5):372-376.

30. 김재용, …, 이준영 등 “우리나라 당뇨병환자의 외래이용 지속성이 건강결과(health outcome)와

의료비에 미치는 영향: 건강보험자료 분석결과”, 대한당뇨병학회지 2006;30(5):377-387.

31. 이준영 등 “일반화가능도 이론을 적용한 삷의 질 관련 단일건강수준지표(SMPH) 측정을 위한

실험설계”, 한국자료분석학회지 2005;7(6):1971-1984.

32. 손근주, …, 이준영 등.“유방암 환자의 통증, 우울 및 불안 증상 조절에 아로마 자가 치료의 효과”,

한국호스피스완화의료학회지 2005;8(1):18-29.

33. 송동호, …, 이준영 등.“제주지역 소아의 경골 염전”, 대한소아과학회지 2005;48(1):75-80.

34. 최윤선, …, 이준영 등. “암성통증: 제 5 의 활력징후인 통증의 강도 측정 및 펜타닐 패취

(듀로제식)의 통증 조절 효과”, 한국호스피스완화의료학회지 2004;7(2):238-247.

35. 김금희, …, 이준영 등.“사체간이식 환자와 생체간이식 환자들의 삶의 질 비교 연구”,

한국의료 QA 학회지 2004;11(1):32-45.

36. 기명, …, 이준영 등.“산업안전보건 영역에서 다국적 기업의 이중 기준 적용실태와 영향요인”,

예방의학회지 2004;37(1):17-25.

37. 최수연, …, 이준영 등. “리더십 유형이 구성원의 조직몰입과 직무만족에 미치는 영향: 종합병원

의무기록실을 대상으로”, 한국의료 QA 학회지 2003;10(2):144-153.

38. 최윤선, 이준영 등. “표준형 성인 암성 통증 평가 도구(K-CPAT): 설문조사의 신뢰도 및 타당도

평가”, 한국호스피스완화의료학회지 2003;6(2):152-163.

39. Je BK, …, Lee J, et al. “Benign versus malignant solid nodules in subareolar area of the breast: Radiological, clinical and pathological correlation” Journal of Korean Society of Medical Ultrasound

2003;22:143-149. (In English)

40. 김진서, …, 이준영 등. “'표준형 성인 암성 통증 평가도구'개발을 위한 시각통증등급의

최고통증강도 어휘 및 심리,사회적 평가 항목의 선정 - 델파이 방법을 이용 -”,

한국호스피스완화의료학회지 2003;6(1):11-21.

20

41. 정혜경, …, 이준영 등. “응급실 급성심근경색증 환자의 체류시간에 영향을 미치는 요인에 관한

연구”, 한국의료 QA 학회지 2003;10(1):42-56.

42. Seo BK, …, Lee J, et al. “A comparison study between compound imaging and conventional ultrasonography in subareolar area” Journal of Korean Breast Cancer Society 2003;6(1):15-19. (In

English)

43. 배희준, 이준영 등. “두개내 동맥경화에 고지혈증이 미치는 영향에 대한 평가”, 범석학술논문집

2003;7:299-307.

44. 박종순, 이준영, 김순덕. “우리나라에서 경제성장률과 실업률이 자살률에 미치는 영향”,

예방의학회지 2003;36(1):85-91.

45. 김형수, …, 이준영 등. “직업관련성 뇌혈관 및 심장질환의 비용”, 대한산업의학회지

2002;14(3):288-300.

46. 서보경, …, 이준영 등. “유방암 관찰 시 실시간 복합영상기법이 고식적 초음파보다 우수한가?”,

한국유방암학회지 2002;5(2):102-107.

47. 이영란, …, 이준영 등. “한국 여성에서 연령에 따른 유방암의 방사선학적, 병리학적, 임상적

소견의 비교연구”, 한국유방암학회지 2002;5(2):91-101.

48. 이준영. “SPSS 를 이용한 통계분석”, 대한임상화학검사학회지 2002; 11(1): 16-22.

49. 손원용, 이준영, 박정호. “한국인의 특발성 대퇴골두 무혈성 괴사에서 혈액응고 장애”,

대한정형외과학회지 2002;37(2):245-250.

50. 당장리, …, 이준영. “일차진료의 흔한 문제에 대한 치료의 과학적 근거수준 평가 - 일개 대학병원

가정의학과 외래환자를 대상으로 -”, 가정의학회지 2002;23(1):40-59.

51. 이준영. “일반화된 선형혼합모형(Generalized Linear Mixed Model: GLMM)에 관한 최근의

연구동향”, 응용통계연구 2000;13(2):541-562.

52. 이준영. “일반화된 선형혼합모형: 선형혼합모형과 일반화된 선형모형의 연결”, 응용통계,

고려대학교 통계연구소 1999;14:27-40.

53. 신한풍, 이준영. "통계학과 농업: 1940 년 이후의 역사“, 응용통계, 고려대학교 통계연구소

1989;4(1):37-49.

54. 이준영, 신한풍. “일반화된 ABO-식 혈액형의 유전자 빈도에 대한 최우추정 및 검정”,

응용통계연구 1989;2(1):35-47.

55. 신한풍, 이준영. "통계학과 농업: 1940 년 이전의 역사“, 응용통계, 고려대학교 통계연구소

1988;3(1):5-19.

- EOD -